Caldwell Sutter Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.27K Hold
6
– – ﹤0.01% 808
2026
Q2
$1.76K Hold
6
– – ﹤0.01% 815
2026
Q1
$1.67K Hold
6
– – ﹤0.01% 771
2025
Q4
$1.82K Hold
6
– – ﹤0.01% 755
2025
Q3
$1.68K Hold
6
– – ﹤0.01% 756
2025
Q2
$1.45K Hold
6
– – ﹤0.01% 752
2025
Q1
$1.46K Hold
6
– – ﹤0.01% 766
2024
Q4
$1.97K Hold
6
– – ﹤0.01% 747
2024
Q3
$2.01K Hold
6
– – ﹤0.01% 758
2024
Q2
$1.64K Hold
6
– – ﹤0.01% 778
2024
Q1
$2.08K Hold
6
– – ﹤0.01% 754
2023
Q4
$1.94K Hold
6
– – ﹤0.01% 766
2023
Q3
$2.15K Hold
6
– – ﹤0.01% 722
2023
Q2
$2.28K Buy
+6
New +$2.44K ﹤0.01% 726

Other funds holding BIO

Caldwell Sutter Capital's BIO Position: Q3 2026 in Review

Caldwell Sutter Capital held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 6 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Caldwell Sutter Capital first reported a position in BIO in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.28K in Q2 2023. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Caldwell Sutter Capital held 6 shares of Bio-Rad Laboratories Class A worth $2.27K as of Q3 2026.
  • Caldwell Sutter Capital left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q3 2026, its #808 holding.
  • Caldwell Sutter Capital first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and has held it in 14 quarters since.
  • Caldwell Sutter Capital's Bio-Rad Laboratories Class A position peaked at $2.28K in Q2 2023.
  • 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Caldwell Sutter Capital's 13F filing for Q3 2026, filed 9 Nov 2026.